Lotemax® SM (loteprednol etabonate) – New Drug Approval
February 25, 2019 - Bausch and Lomb announced the FDA approval of Lotemax SM (loteprednol etabonate) 0.38% ophthalmic gel, for the treatment of postoperative inflammation and pain following ocular surgery.
Download PDF
